EASL Clinical Practice Guidelines on vascular diseases of the liver

,

    Journal of Hepatology
    |November 12, 2025
    PubMed

    Insights

    New guidelines offer evidence-based recommendations for diagnosing and managing rare vascular liver diseases. Personalized, multidisciplinary care is crucial for conditions like Budd-Chiari syndrome and portal vein thrombosis.

    Area of Science:

    • Hepatology
    • Vascular Medicine
    • Interventional Radiology

    Background:

    • Vascular liver diseases encompass rare conditions like Budd-Chiari syndrome and portal vein thrombosis.
    • Recent advancements necessitate updated clinical practice guidelines since 2016.

    Purpose of the Study:

    • To provide evidence-based recommendations for diagnosing and managing vascular liver diseases.
    • To address key clinical dilemmas and promote personalized patient care.

    Main Methods:

    • Comprehensive literature review of published data on diagnosis and management.
    • Synthesis of evidence to formulate clinical recommendations.

    Main Results:

    • Updated guidance on medical and interventional management strategies.
    • Emphasis on individualized treatment based on risk factors and presentation.

    Conclusions:

    • Multidisciplinary collaboration is essential for optimal patient outcomes.
    • Personalized, evidence-based management is key for rare vascular liver conditions.

    Related Concept Videos

    Esophageal Varices-II: Clinical Features and Management01:28

    Esophageal Varices-II: Clinical Features and Management

    Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
    In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
    355
    Diseases of the Liver and Gallbladder01:26

    Diseases of the Liver and Gallbladder

    Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
    Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
    1.8K
    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

    In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
    171
    Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

    Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

    Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
    339
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    307
    Peripheral Artery Disease IV: Nursing Management01:26

    Peripheral Artery Disease IV: Nursing Management

     The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
    329